ALBANY, N.Y. — New York is inching toward legalizing some form of
medical marijuana as support grows in the state Legislature and is
likely to become one of a handful of issues taken up when lawmakers
return later this month.
But it remains unclear where the drug would come from for either Gov.
Andrew Cuomo's limited research program or broader, legalized use under
a proposed medical marijuana bill.
Marijuana for clinical trials
comes from the National Institute on Drug Abuse, which has a contract
with the University of Mississippi to grow marijuana for studies, a
spokeswoman for the Food and Drug Administration said.
"Obtaining marijuana for research along these lines is notoriously
difficult, but not impossible," said Gabriel Sayegh, the New York state
director of the Drug Policy Alliance, which advocates for a public
health approach to drug abuse rather than relying on the criminal
justice system.
A spokesman for Cuomo referred questions to the state's health
department, which would oversee New York's medical marijuana program. A
spokesman for the agency said this week that a "senior-level team"
within the department was developing the framework for the research
program, but calls seeking elaboration weren't returned.
It is unclear how particular strains of the drug could be brought
into the state without violating federal law, which prohibits
transporting marijuana across state lines. Calls made to the sponsors of
the medical marijuana bill, Sen. Diane Savino and Assemblyman Richard
Gottfried, weren't returned.
In neighboring New Jersey, Tom Prendergast, a manager at one of that
state's three dispensaries, said in an interview that the initial seeds
and plants came from out of the state, but would not elaborate for legal
reasons.
Advocates for the legalized medical marijuana say that the drug can
ease nausea, appetite loss and pain associated with such illnesses as
cancer, AIDS or epilepsy. Certain strains that are low in THC have also
shown seizure-fighting properties, and in October, the FDA approved
testing of a British pharmaceutical firm's marijuana-derived drug that
contains a property that may combat seizures.
Savino, member of a group of breakaway Democrats that control the
Senate with the Republicans, has said she has more than enough votes to
pass the bill in the Senate. The Democratic-led Assembly has passed the
bill.
"Should the Senate decide to take up the bill, we would be delighted to pass it once again," Assembly Speaker Sheldon Silver said in a statement Tuesday that came after he told reporters that the bill didn't seem to have "a future in this session."
Senate Republican leader Dean Skelos can block bills from a floor
vote by using the veto power that he and the leader of the breakaway
Democrats hold under their power-sharing agreement.
A spokesman for Skelos said the senator was taking a "cautious approach."
"Sen. Skelos has indicated that he is seeking additional information
and will continue to study this issue," Skelos' spokesman said.
A Siena poll released in March found that 47 percent of New Yorkers
support legalizing marijuana while 31 percent support Cuomo's plan to
allow medical marijuana research in 20 hospitals.
Studio33
http://www.amazon.com/shops/studio33
Virgin Atlantic Airways
http://tinyurl.com/pjbm6r6
Luxury French Lingerie
http://tinyurl.com/o7qcz7m
From chocolate eggs to chocolate coins, give your sweet tooth a treat with our delicious products.
http://tinyurl.com/nragc9j
Astore
http://astore.amazon.com/nevinghomebas-20
No comments:
Post a Comment